Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010.

Authors:
Address: Service de bactériologie médicale, institut Pasteur d'Algérie, Algiers, Algeria. htali@yahoo.fr
Journal:

Publication:

abstract

INTRODUCTION:

Pneumococcal infections are a major public health problem because of the virulence of this bacterium and its ability to develop resistance.

MATERIAL AND METHOD:

Two hundred and ninety-four strains of Streptococcus pneumoniae were isolated from sterile (56.8%) and non-sterile samples (43.2%), from January 2001 to July 2010.

RESULTS:

The interpretation of antibiotic susceptibility testing, according to CLSI criteria (M100-S21 2011), yielded a 25.2% overall resistance to penicillin, with 23.5% of strains isolated from CSF (meningitis), and only 1.7% in other samples. Resistance to cefotaxime was 8.1% (including 4.4% at a high level). The most common serotypes were: 14 (19.5%), 23F (9.7%), 6B (9.3%), 19F (5.4%), and serotype 1 (5%). The percentage of these serotypes isolated from normally sterile sites in children under 5 years of age was 31.25% for 14, 10.4% for 23F, 8.3% for 19F, 6.25% for 6B, and 4.2% for serotype 1. The theoretical vaccinal coverage against invasive infections in children under 2 years of age was 61.5%, 69.2%, and 76.9% for the 7-valent, 10-valent, and 13-valent conjugate vaccines, respectively. Penicillin non-susceptible Streptococcus pneumoniae (PNSP) strains accounted for 67.1, 68.6, and 72.8% for each of these three vaccines.

CONCLUSION:

There was a variation of serotype rates compared to previous studies. The increase in pneumococcal antibiotic resistance is concerning, particularly for the treatment of pneumococcal infections in children and infants. Pneumococcal vaccination is not compulsory yet in Algeria.

Related Articles
[Serotype distribution and resistance to beta-lactams of Streptococcus pneumoniae isolated from children in Beijing, Shanghai and Guangzhou, 2000 - 2002].
Zhonghua Er Ke Za Zhi. 2006
[Serotype distribution and resistance to beta-lactams of Streptococcus pneumoniae isolated from children in Beijing, Shanghai and Guangzhou, 2000 - 2002].
Yao KH, Lu Q, Deng L, Yu SJ, Zhang H, Deng QL, Tong YJ, Gao W, Yuan L, Shen XZ, et al. Zhonghua Er Ke Za Zhi. 2006 Dec; 44(12):928-32.
Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia.
PLoS One. 2011
Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia.
Le CF, Palanisamy NK, Mohd Yusof MY, Sekaran SD. PLoS One. 2011; 6(5):e19547. Epub 2011 May 16.
Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.
Clin Vaccine Immunol. 2008
Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.
Mokaddas EM, Rotimi VO, Albert MJ. Clin Vaccine Immunol. 2008 Feb; 15(2):203-7. Epub 2007 Dec 12.
Review Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Int J Infect Dis. 2010
Review Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ, McIntosh ED, Reinert RR. Int J Infect Dis. 2010 Mar; 14(3):e197-209. Epub 2009 Aug 22.
Review Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.
Clin Microbiol Infect. 2010
Review Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.
Liñares J, Ardanuy C, Pallares R, Fenoll A. Clin Microbiol Infect. 2010 May; 16(5):402-10. Epub 2010 Feb 2.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.